Although CTGF is involved in peritoneal fibrosis, additional studies will be necessary to characterize its potential as a pharmacological target as it lacks a specific receptor, it has several isoforms, and it interacts with multiple factors (bone morphogenic factors, VEGF, Wnt, integrins, heparan sulfate proteoglycans, and epidermal growth factor receptor) [100]. Here, CCN2 is linked to Peritoneal Fibrosis.